English
  • استرجاع مجاني وسهل
  • أفضل العروض

Pharmaceutical Innovation

الآن:
387.00 د.إ.‏شامل ضريبة القيمة المضافة
noon-marketplace
احصل عليه خلال 15 يناير
اطلب في غضون 7 ساعة 41 دقيقة
VIP ENBD Credit Card

emi
خطط الدفع الشهرية تبدأ من د.إ.‏33عرض المزيد من التفاصيل
VIP card

احصل على د.إ. 19.35 رصيد مسترجع باستخدام بطاقة بنك المشرق نون الائتمانية. اشترك الآن. قدّم الحين

ادفع على 4 دفعات بدون فوائد بقيمة ٩٦٫٧٥ د.إ.اعرف المزيد
قسمها على 4 دفعات ب ٩٦٫٧٥ د.إ. بدون فوائد أو رسوم تأخير.اعرف المزيد
التوصيل 
بواسطة نوون
التوصيل بواسطة نوون
البائع ذو
 تقييم عالي
البائع ذو تقييم عالي
الدفع 
عند الاستلام
الدفع عند الاستلام
عملية 
تحويل آمنة
عملية تحويل آمنة
1
1 تمت الإضافة لعربة التسوق
أضف للعربة
Noon Locker
توصيل مجاني لنقطة نون ومراكز الاستلام
معرفة المزيد
free_returns
إرجاع سهل لكل المنتجات في هذا العرض.
المنتج كما في الوصف
المنتج كما في الوصف
70%
شريك لنون منذ

شريك لنون منذ

7+ سنين
نظرة عامة
المواصفات
الناشرCambridge University Press
رقم الكتاب المعياري الدولي 139780521874908
وصف الكتابThe pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.
عن المؤلفFrank Sloan has been the J. Alexander McMahon Professor of Health Policy and Management and Professor of Economics at Duke University since 1993, where he holds faculty appointments in the Department of Economics, the School of Public Policy, the Fuqua School of Business, and the School of Nursing. Before joining the faculty at Duke, he was a research economist at the Rand Corporation and served on the faculties of the University of Florida and Vanderbilt University. His current research interests include alcohol use and smoking prevention, long-term care, medical malpractice, and cost-effectiveness analyses of medical technologies. Professor Sloan also has a long-standing interest in hospitals, health care financing, and health manpower. He has served on several national advisory public and private groups, including the Physician Payment Review Commission. He has been a member of the Institute of Medicine of the National Academy of Sciences since 1982, recently chairing IOM committees on vaccine financing and cancer in low- and middle-income countries. He recently received a Merit Award from the National Institutes of Health and an Investigator Award from the Robert Wood Johnson Foundation. Professor Sloan's most recent books include The Smoking Puzzle: Information, Risk Perceptions, and Choice (2003) with Drs V. Kerry Smith and Donald H. Taylor, Jr., and The Price of Smoking with Drs Jan Ostermann, Gabriel Picone, Christopher Conover, and Donald H. Taylor, Jr. (2004). Professor Sloan received his Ph.D. in economics from Harvard University in 1969.
اللغةEnglish
تاريخ النشر20070430
عدد الصفحات346

Pharmaceutical Innovation

تمت الإضافة لعربة التسوقatc
مجموع السلة 387.00 د.إ.‏
Loading